DAIC

JULY 29, 2024

mtaschetta-millane Mon, 07/29/2024 - 09:02 July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth.

Innovation 98

Innovation Aortic valve Aortic CMS 98

DAIC

DECEMBER 22, 2023

Tricuspid regurgitation (TR) is a common and serious disease for which open heart surgery and symptomatic pharmacologic treatment are the current standard treatment options. Topaz is an innovative, minimally invasive device designed specifically to help patients suffering from severe TR, without the need for open heart surgery.

Tricuspid 59

Tricuspid Pacemaker Heart Valves Open-Heart Surgery 59

DAIC

APRIL 2, 2024

Food and Drug Administration (FDA) approval of its TriClip, a first-of-its-kind device to repair leaky tricuspid heart valve, for which more than 1.6 TR occurs when the valve doesn't close properly, causing a leak and allowing blood to flow backward in the heart. Abbott has announced U.S million people in the U.S.

Tricuspid 105

Tricuspid Heart Valves Quality of Life Open-Heart Surgery 105

DAIC

JUNE 11, 2024

Tricuspid and mitral valves are debilitating conditions that can lead to arrhythmias, hypertension, and heart failure. Until recently, therapeutic options for people with tricuspid and mitral valve disorders have been limited to symptom relief or high-risk surgery.

Tricuspid 111

Tricuspid Bicuspid/Mitral Heart Valves Innovation 111

DAIC

MARCH 8, 2024

suffer from heart failure , and there are approximately 400,000 heart-failure-related deaths in this country each year. Patients with heart failure often experience reduced mobility, quality of life and ability to work; the disease also represents a significant public health care burden.

Blood Clot 98

Blood Clot Heart Failure Quality of Life Innovation 98

DAIC

JANUARY 16, 2024

Shreenivas is a frequent speaker at major scientific meetings and has been widely published in peer-reviewed journals across the structural heart, heart failure, and coronary arenas. The Carillon Mitral Contour System is designed to treat both FMR and heart failure in one simple, short, minimally-invasive procedure.

Bicuspid/Mitral 59

Bicuspid/Mitral Heart Failure Catheterization Laboratory Innovation 59

DAIC

JUNE 13, 2024

Getty Images milla1cf Thu, 06/13/2024 - 20:38 June 13, 2024 — Medtronic plc, a global leader in healthcare technology, today announced the launch of its latest innovation in cardiac surgery, the Avalus Ultra valve. A treatment for patients with aortic valve disease is surgical aortic valve replacement (SAVR).

Aortic valve 109

Aortic valve Aortic Innovation Cardiothoracic 109